Anocca
Anocca comments on the SEK 440 million financing
The capital from the financing round will be used to drive the clinical development of VIDAR-1, the company's gene-edited TCR-T therapy for pancreatic cancer, as well as...
Bioteknik
News roundup Tuesday, March 18
Zhida Pharmaceutical
News roundup Monday, September 9
BioInvent
News roundup Thursday, March 14
The latest from BioStock
Significant injections into Vicore Pharma and Anocca
Despite the challenges in the capital markets, biotech companies Vicore Pharma...
News roundup Wednesday, May 31
BioStock Life Science Spring Summit
Scandinavia well represented at JP Morgan Week in San Francisco
Today the JP Morgan Healthcare Conference begins in San...